← Leaderboards
Maria Ferrari
Bioqual, Inc.
$2,583,680
Attributed
$2,583,680
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2022–23$2M$1.5M$1M$500K$0
'22
'23
Funding mix
By agency
NIH$2,583,680 · 1
By mechanism
N01$2,583,680 · 1
Top collaborators
No co-investigators on record.
Most similar at Bioqual, Inc.
Same institution · by research overlap
- Mark Lewis$23,081,773
- Deborah Weiss$695,753
- Hanne Andersen$3,809,803
- Maria Grazia Ferrari$1,216,423
- Richard P Bradbury$69,368
Others in their field
Other Rising Stars on “Virus Diseases”
- Gene Garrard Olinger · University Of Texas Med Br Galveston$23,000,000
- Kevin V Grimes · Stanford University$14,783,804
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Michael George Natchus · Emory University$10,548,554
- Anice Lowen · Emory University$10,193,979
- Joseph Fraser Glickman · Hackensack University Medical Center$8,363,749
Research focus
Virus DiseasesPrevention ResearchPrevention StrategyProgramsResearch Clinical TestingResearch PersonnelResourcesUnited States National Institutes Of HealthVaccine EfficacyVaccine EvaluationVaccine ResearchVaccinesVirusAids PreventionAids VaccinesBreedingClinical EfficacyEvaluationEvaluation/TestingFlexibilityHiv VaccineHousingImmune ResponseImmunogenicity
Grant awards (2)
Protection against Mucosal SIV Challenge by Adeno-Associated Virus Delivery of Env-Specific Antibodies$1,999,460
N01 · FY2023 · AI · contact PI
Evaluation of the ability of Mucosal Adjuvant Properties of an HIV mRNA vaccine to enhance protection provided by ADCC and Efferocytosis of Infected Cells$584,220
N01 · FY2022 · AI · contact PI